Oncologic Therapy Support Via Means of a Dedicated Mobile App

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present single-center prospective exploratory study, conducted at Heidelberg University Hospital, assesses the feasibility of introducing a concept for additional patient care based on a mobile application for patients undergoing radiotherapy. Patients presenting themselves for the irradiation of thoracic or pelvic tumors will be surveyed regarding general performance, treatment-related Quality of Life (QoL) and symptoms and their need to personally consult a physician on a treatment-daily basis by means of a mobile application. The primary endpoint of feasibility will be reached when 80% of the patients have successfully answered 80% of their respective questions scheduled for each treatment day. Furthermore, treatment-related patient satisfaction and diagnosis-related QoL is assessed by PSQ-18 and EORTC questionnaires at the end of radiotherapy and at the first follow-up.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Geriatric-oncological Study on Quality of Life and Independence After Radiotherapy

NCT05187845

Cancer Age <70

COMPLETED

Pelvic Cancer Registry for Online Adapted Radiotherapy

NCT06185062

Pelvic Tumor Thoracic Tumor

RECRUITING

Adaptive Radiotherapy in Patients With Gynecological Tumors

NCT06230549

Gynecological Tumor Adaptive Radiotherapy Radiation +5 more

RECRUITING NA

Improving Quality of Life and Function for Older Cancer Patients Receiving Radiotherapy

NCT03071640

Elderly Cancer Radiotherapy Side Effect

COMPLETED

A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy

NCT05173961

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thoracic Neoplasm Pelvic Neoplasm Radiotherapy; Complications Oncologic Disorders Breast Cancer Satisfaction Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Single-center prospective exploratory study

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mobile application

Patients undergoing radiotherapy will receive additional therapy support by an application installed on a mobile device

Group Type EXPERIMENTAL

mobile application

Intervention Type OTHER

Oncologic therapy support by means of a mobile application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mobile application

Oncologic therapy support by means of a mobile application

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indication for radiotherapy with potentially curative intent of a primarily thoracic or pelvic target
* Karnofsky performance score (KPS) ≥ 70%,
* Ability to initiate the therapy as an outpatient
* ≥ 18 years of age